The granulocyte/macrophage colonystimulating factor (GM-CSF) receptor (GMR) transduces a signal that results in the proliferation, differentiation, and functional activation of hematopoietic cells. This study sought to determine whether functional isoforms of the receptor exist that may be important in generating this diversity of cellular response. We have isolated a cDNA encoding an isoform of the low-affinity human GMR that is a product of alternative splicing of the GMR gene and results in a predicted 410-amino acid protein with a cytoplasmic domain that is rich in serine residues, a feature of regions critical in signal transduction for other receptors of the hematopoietin receptor superfamily. This receptor bound ligand and was functionally active when introduced into a murine factor-dependent cell line; mRNA transcripts representative of this isoform were coexpressed with those for a previously isolated 400-amino acid isoform of the GMR in normal hematopoietic and leukemic cells. In view of the recent isolation of a cDNA, designated GM-CSF R", that confers high-affinity binding of GM-CSF in cotransfection experiments with the low-affinity receptor, we suggest that the previously isolated low-affinity receptor be designated GM-CSF Ral and the one described in this report be designated GM-CSF Ra2.
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Hematopoietic development is regulated by a family of growth factors that mediate cell proliferation, differentiation, and function. One of these, granulocyte/macrophage colonystimulating factor (GM-;CSF), induces the proliferation and differentiation of granulocyte and macrophage progenitors and, in combination with erythropoietin, supports the development of erythroid progenitors in vitro (1, 2) . Mature neutrophils, eosinophils, and monocytes become functionally activated following exposure to GM-CSF (2) . These effects on hematopoietic cells have been confirmed in vivo (3) (4) (5) (6) and are mediated following binding of the growth factor to a specific cell surface receptor (the GMR) (7) (8) (9) . High-and low-affinity GMRs are expressed in low abundance on hematopoietic cells (50-500 per cell), and cross-linking studies suggest that they have more than one subunit (7) (8) (9) (10) (11) (12) (13) . Furthermore, at 40C cells that express both the GMR and the interleukin 3 (IL-3) receptor show cross-competition; GM-CSF competes for binding of IL-3 to its receptor and vice versa (11) (12) (13) (14) (15) (16) . This raises the possibility that the GMR and the IL-3 receptor share a common subunit. A cDNA clone encoding a GMR that binds human GM-CSF with low affinity has been isolated from a human placental library (17) and the gene for this receptor has been mapped to the X-Y pseudoautosomal region (18) . Although this GMR is functional in that it confers human GM-CSF responsiveness on a factordependent cell line (19) , the cytoplasmic domain is relatively short, and the 54 amino acids within this domain do not contain motifs known to be associated with signal transduction. It also lacks the serine-rich domains shown to be critical in receptor function for two members of the hematopoietin receptor superfamily (17, (20) (21) (22) , the 8 chain of the interleukin 2 receptor (23) and the erythropoietin receptor (24) . Therefore it is likely that additional proteins associate with this low-affinity GMR to mediate signal transduction and convert it to a receptor that binds with high affinity. Indeed, a cDNA clone has recently been isolated that does not bind GM-CSF itself but confers high-affinity binding when cotransfected with the low-affinity GMR (25) . These data, combined with the knowledge that GM-CSF can exert pleiotropic effects on hematopoietic cells, led us to consider whether isoforms of the GMR may exist as one of the means to generate the complexity of cellular responses observed.
MATERIALS AND METHODS
Construction and Screening of the cDNA Library. Poly(A)+ RNA from the cell line M-07 (26) was converted to doublestranded cDNA using oligo(dT) primers. A cDNA library was then constructed in the expression vector pMT 21, a derivative of pMT 2 (27) . This library was screened on nitrocellulose filters (28) with a probe derived by the polymerase chain reaction (PCR) from a pool of 100,000 M-07 cDNAs and oligonucleotides complementary to the extracellular and 3' untranslated regions ofthe published GMR sequence [ref. 17 Electroporation. FDC-P1 cells (31) were coelectroporated with linearized constructs of GMR.B (50 ,tg) and the neomycin-resistance gene (10 ,ug) , both in the expression vector pMT 21 . Electroporation was performed in serum-free RPMI 1640 medium with conditions of 980 ,F and 250 V. Cells were selected for growth first in G418 and then in human GM-CSF.
Radioiodination of GM-CSF and Binding Studies. Recombinant human GM-CSF (derived from Escherichia colt) was iodinated using the iodine monochloride method as published previously (32) . This procedure resulted in 1251-labeled GM-CSF with a specific activity of 20,000-40,000 cpm/ng by self-displacement analysis and a biological activity of 80-100% in progenitor assays.
Binding experiments were performed as described previously (9) . Prior to these studies, FDC-P1 cells that had been maintained in human GM-CSF were washed and incubated in cytokine-free medium for 6 hr. Binding assays were performed at 4°C overnight. Cells (7.5 (25) , which expresses both GM-CSF and IL-3 receptors. This library was screened with a probe obtained by PCR amplification of a fragment predicted from the published GMR sequence (GMR.A) to be 449 base pair (bp) long. However, by restriction enzyme digestion, the PCR product appeared to lack approximately 100 bp between the Sac I and the EcoRI sites (Fig. 1A) . Sequence analysis of the probe showed that a deletion of 97 bp had resulted in complete loss of sequences corresponding to the transmembrane domain of the receptor (data not shown). Examination of genomic clones showed that the deletion had occurred precisely at splice junctions (data not shown).
When this probe was used to screen 215,000 clones of the M-07 library, a single positive clone was isolated. This clone (GMR.B) was 1480 bp long and lacked a poly(A) tail. Molecular analysis of the GMR.B clone showed nucleotide identity between this cDNA and that of GMR.A in the extracellular, transmembrane, and proximal cytoplasmic domains but complete lack of similarity in the distal cytoplasmic region (Fig. 1A) . The intracellular domain of this clone encodes 64 amino acids (compared with 54 amino acids for GMR.A) and it is rich in serine and proline residues (Fig. 1B) . Of the 35 nonhomologous amino acids, seven are serine residues and six are proline residues. Comparison of the nucleotide and amino acid sequences of GMR.B with sequences available in GenBank (February 1990) showed no highly significant similarities.
Southern Analysis and Characterization of Genomic Clones Encoding the GMR. To ensure that the GMR.B cytoplasmic region was not an artifact of library construction, human DNA was digested with a variety of restriction enzymes and, after transfer to nitrocellulose, probed with sequences specific for the common or unusual regions of GMR.B. This analysis revealed that most bands are shared between the two probes and suggested that GMR.B is derived from the same gene as GMR.A (data not shown). To confirm this observation and determine the molecular mechanism by which GMR.A and GMR.B had arisen, genomic clones were isolated from a human genomic DNA library. One of the clones isolated hybridized to a probe that contained only the unusual sequences of GMR.B. Sequence analysis of a fragment that hybridized to this probe revealed the presence of splice donor and acceptor sites separated by intronic sequences at the point of divergence between GMR.A and GMR.B cDNAs (Fig. 1C) . Further mapping and sequencing place the GMR.B exon 5' to sequences encoding the 3' end of GMR.A (data not shown).
The existence of alternatively spliced transcripts for the GMR gene prompted us to screen an additional 200,000 clones from the unamplified M-07 library as well as from a human placental library with a full-length GMR.B probe. We identified three positive clones from the M-07 library, two of which were identical to GMR.A and one of which was identical to GMR.B. One full-length clone isolated from the human placental library was identical to GMR.A (data not shown). Clones containing a transmembrane deletion, as suggested by the original PCR probe, were not isolated from either library. However, similar deletions have been observed in other receptors of the hematopoietin family, and secreted forms of such receptors that lack a transmembrane domain have been isolated (33) (34) (35) . Another group has also recently reported the isolation, by PCR, of GMR cDNAs that lack 97 bp encoding the putative transmembrane domain (36) .
Expression of GMR Isoforms in Normal Tissues and in M-07 Cells. We next determined whether mRNA species that represent GMR.B are present in normal cells or whether these transcripts are unique to the leukemic cell line M-07. To this end, RNase protection analysis was performed with a probe derived from GMR.B (Fig. 2) . GMR.B transcripts should protect a 421-nucleotide (nt) fragment whereas GMR.A transcripts should protect a 230-nt fragment. Fig. 2 demonstrates the presence of transcripts for both of the receptor isoforms, not only in M-07 cells but also in human bone marrow and placenta. The T-lymphoma cell line Jurkat, which does not bind 1"-I-labeled human GM-CSF (37) , lacked transcripts for both GMR isoforms. The relative abundances of the mRNAs showed a predominance of GMR.A, with levels of GMR.B :10-fold less as assessed by scanning densitometry. Prominent bands at 135 nt and 85 nt were present in M-07 cells, bone marrow, and placenta but not in GMR.B-transfected COS-1 cells. These protected fragments are distinct from other bands of <421 nt present in all lanes (considered to be cleavage products of larger species) and may represent additional receptor isoforms. We also note that the 85-nt protected fragment shown in the M-07, bone marrow, and placenta lanes is consistent with the existence of GMR transcripts that lack the 97-nt transmembrane region deleted in the PCR probe.
Binding and Growth Characteristics of FDC-P1 Cells That Stably Express GMR.B. To examine whether the cDNA for GMR.B encodes a functional receptor, stable lines of the munne factor-dependent cell line FDC-P1 (30) , which expresses GMR.B, were established. Parental FDC-P1 cells proliferate in response to both murine IL-3 and murine GM-CSF but not to human GM-CSF. We reasoned that if the signal transduction components of the murine cell are able to interact with a human GMR, cells that express GMR.B might proliferate in response to human GM-CSF and confirm that the receptor is functional. FDC-P1 cells were electroporated with a cDNA encoding GMR.B and a separate construct containing the neomycin-resistance gene. A cloned cell line, selected for growth in G418 and then in human GM-CSF, was shown to contain mRNA transcripts for GMR.B (Fig. 3A) .
FDC-P1 cells that expressed GMR.B bound 1251-labeled human GM-CSF with a Kd of 4 nM (Fig. 3B) , an affinity similar to that seen with the transiently transfected receptor in COS-1 cells. This affinity agrees with that observed for GMR.A (17) . Scatchard analysis of the binding demonstrated the presence of approximately 77,000 sites per cell (Fig. 3B  Inset) . Cross-linking of the transfected receptor in COS-1 cells with '25I-labeled human GM-CSF and disuccinimidyl suberate demonstrated a broad band of approximate Mr 100,000, consistent with ligand bound to a glycosylated receptor of Mr 85,000 (data not shown).
In addition to binding GM-CSF, the receptor was capable of transducing a proliferative signal. The growth of transfected FDC-P1 cells was supported in a dose-dependent manner by human GM-CSF alone (Fig. 3C) . Although a high concentration of ligand, consistent with a low binding affinity, was required for proliferation, these cells were capable of a maximal proliferative response to human GM-CSF equivalent to that achieved in the presence of murine IL-3 or munne GM-CSF. The cells maintained parental-type responses, in the picomolar range, to murine IL-3 and GM-CSF. In the same assay, M-07 cells (which express highaffinity GM-CSF receptors) exhibited a peak proliferative response to human GM-CSF in concentrations as low as 1 ng/ml (data not shown). GMR.B-transfected FDC-P1 cells remained factor-dependent for growth and could be maintained long-term (>6 months) in medium containing only human GM-CSF.
DISCUSSION
These results demonstrate the existence of a second protein that binds human GM-CSF and can transduce a signal. This receptor isoform is a result of alternative splicing of the GMR gene. Its expression is not restricted to a leukemic cell line but is found in normal tissues and is likely to have functional significance. The isoform we describe has a cytoplasmic domain that is rich in serine and proline residues, similar to regions of the interleukin 2f3 chain and erythropoietin receptors that have been shown to be critical for signal transduction. A relative abundance of serine and proline residues has also been noted in the cytoplasmic regions of the receptors for IL-3, interleukin 4, and interleukin 7 (33, 34, 38) , although a role for these amino acids in intracellular signaling via these receptors has yet to be firmly established. In addition, this study suggests the existence of other GMR isoforms in addition to GMR.A and GMR.B. In particular, it is likely from our PCR analysis (and ref. 36 ) that a form of the GMR lacks the transmembrane domain and thus may occur as a soluble form. Furthermore, a human cDNA clone was recently isolated that does not bind GM-CSF itself but confers high-affinity binding on the low-affinity GMR when Cell Biology: Crosier et al.
Proc. Natl. Acad. Sci. USA 88 (1991) cDNAs that encode both polypeptides are cotransfected into COS cells (25) .
Evidence is accumulating that alternative splicing is a mechanism by which receptor heterogeneity is generated, and recently three different mRNAs encoding the receptor for human granulocyte colony-stimulating factor have been identified (35) . It is noteworthy that while one mRNA encoded a putative secreted receptor, another receptor class contained a 27-amino acid insertion within the cytoplasmic domain that did not alter the translational reading frame. It would seem that receptors with different cytoplasmic domains may be another general feature of the hematopoietin receptor superfamily.
GM-CSF is capable of inducing different responses in the immature and mature cells to which it binds. Although the functional significance of the existence of receptor isoforms is not yet understood, it is possible that differential expression of these isoforms plays a role in determining the nature of the cellular response. Future studies must focus on the respective functions of these isoforms, both separately and together, and how they interact with other components ofthe GM-CSF signal transduction pathway.
